Acute ischaemic heart disease, unspecified. Acute ischaemic heart disease, unspecified
Conditions
Interventions
Intervention 1: Second method: In this method 1 mg clove extracts (clove extracts (Indian Clove) as a topical gel, made in Ahura Daru Shiraz, with active ingredient contains 20% Eugenol, in 8 gr tube)
Treatment - Drugs
Placebo
Prevention
Second method: In this method 1 mg clove extracts (clove extracts (Indian Clove) as a topical gel, made in Ahura Daru Shiraz, with active ingredient contains 20% Eugenol, in 8 gr tube) is placed on th
Water soluble lubricant Gel (with brand of playgel, 85 mg tube, made in Paliz Teb Shafagh Iran) is placed on the injection site (2 inches of priumbilical area) with holder dressing 30 minute before th
First method: Injection Enoxaparin without interference (Subcutaneous injection of Enoxaparin-Na for 10 seconds in the right or left side of abdomen)
Sponsors
Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 40-60 years old; full consciousness; ability to communicate; not a severe pain in other areas; no scarring and lesions at the injection site and no history of allergy to clove. Exclusion criteria: loss of consciousness; sensorimotor disorders; injection of other drug in the abdomen during the study, and two days before the study; prescription of narcotic and non-narcotic analgesics 2 hours before injection; allergy to clove extracts.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Immediatly after intervention. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzim Azizi
Hamadan University of Medical Sciences
Outcome results
None listed